In a study conducted by Anna Tylutka et al. in 2023, it was shown that patients with metabolic syndrome have higher levels of inflammatory markers such as TNF-α and High-Mobility Group Box 1 (HMGB1) protein, as well as high body fat and insulin resistance. This evidence concerns the gene TNF and Insulin resistance.